Der Magen 1993
DOI: 10.1007/978-3-662-06526-6_9
|View full text |Cite
|
Sign up to set email alerts
|

Magenschleimproduktion und Magenschleimhautprotektion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…The mechanism of p38-mediated Erk inhibition might relate to high level selectivity of distinct MAPK phosphatases for Erk and p38 (77). The ability of p38 inhibitors to stimulate and/or enhance gastric cell MMP-1 release suggests that they may prove ulcerogenic, consistent with a role for p38 in gastric and oral mucosal healing in humans and rats (78,79). However, in contrast to MMP-1, the ability of p38 inhibitors to inhibit MMP-13 secretion suggests that MMP-13 secretion is positively regulated by p38.…”
Section: Discussionmentioning
confidence: 88%
“…The mechanism of p38-mediated Erk inhibition might relate to high level selectivity of distinct MAPK phosphatases for Erk and p38 (77). The ability of p38 inhibitors to stimulate and/or enhance gastric cell MMP-1 release suggests that they may prove ulcerogenic, consistent with a role for p38 in gastric and oral mucosal healing in humans and rats (78,79). However, in contrast to MMP-1, the ability of p38 inhibitors to inhibit MMP-13 secretion suggests that MMP-13 secretion is positively regulated by p38.…”
Section: Discussionmentioning
confidence: 88%